Daily Digit: AstraZeneca's Pearl of a deal

Reuters Business
June 10, 2013 AT 8:26 AM
AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product pipeline via deal-making. Hayley Platt reports.